Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Tony T. Kalajian currently holds 15,000 shares of OncoCyte Corp (OCX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tony T. Kalajian has been a net buyer of OCX stock. They have purchased $26.4K and sold $0 worth of shares.
Tony T. Kalajian's most recent insider trade was on Aug 3, 2020, when they purchased 5,000 shares at $1.31 per share.
Tony T. Kalajian serves as Executive at OncoCyte Corp (OCX). They have executed 2 insider transactions totaling $26.4K over their tenure at the company.
Tony T. Kalajian holds the position of Executive at OncoCyte Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Tony T. Kalajian has shown a buying trading pattern, with $26.4K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Tony T. Kalajian was on Sep 13, 2019, when they purchased $19.8K worth of OCX shares. This transaction involved 10,000 shares at $1.98 per share.
Tony T. Kalajian currently owns 15,000 shares of OncoCyte Corp (OCX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Tony T. Kalajian's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Tony T. Kalajian has 2 Form 4 filings on record as an insider at OncoCyte Corp.
Set alerts for Tony T. Kalajian and 40,000+ other insiders.